Cigna earnings beat by $0.04, revenue topped estimates
SHENZHEN, China - Meiwu Technology Company Limited (NASDAQ: WNW), a skincare product seller, announced today that it has regained compliance with the Nasdaq’s minimum bid price requirement. The company’s ordinary shares maintained a closing bid price of at least $1.00 for 10 consecutive business days, from April 1 to April 14, 2025. The stock currently trades at $1.24, though it has seen a significant decline of over 97% year-to-date, according to InvestingPro data. This achievement follows Meiwu’s strategic shift from online sales of food products and messaging services to the skincare industry through its subsidiary, Xiamen Chunshang Health Technology Co., Ltd. The company maintains impressive gross profit margins of 45% and shows strong liquidity with a current ratio of 2.64, suggesting adequate resources to fund its transformation.
The Nasdaq Listing Rule 5550(a)(2) stipulates that listed companies must keep their share price above a minimum bid price of $1.00 per share. Meiwu Technology’s compliance with this rule ensures that the company can continue to be traded on the Nasdaq Stock Market. The notification from Nasdaq has officially closed the bid price deficiency matter for Meiwu Technology.
Founded on December 4, 2018, Meiwu Technology is incorporated in the British Virgin Islands and has undergone a significant business transformation. The company now focuses on the sale of functional skincare products, tapping into the health and beauty sector.
The press release also contains forward-looking statements regarding the company’s future performance, which are subject to various risks and uncertainties. These statements are not guarantees of future results and may be affected by factors such as economic conditions, market growth management, and regulatory changes. InvestingPro analysis reveals several additional insights about the company’s potential, with 18 additional ProTips available to subscribers, including detailed valuation metrics and growth indicators. The company’s next earnings report is scheduled for May 12, 2025.
Investors are reminded that Meiwu Technology’s filings with the Securities and Exchange Commission, which can be reviewed at www.sec.gov, contain more detailed information about the company’s risks and uncertainties. With a current market capitalization of just $2.11 million and according to InvestingPro’s Fair Value analysis, the stock appears to be trading below its intrinsic value, though investors should carefully consider the company’s financial health score before making investment decisions.
This news is based on a press release statement from Meiwu Technology Company Limited.
In other recent news, Meiwu Technology Company Limited has announced a 1-for-20 reverse stock split, which was approved by its board and is scheduled to take effect on April 1, 2025. This move will consolidate every 20 existing shares into one new share, reducing the total number of shares from approximately 63.3 million to about 3.2 million. The reverse split is intended to increase the market price of Meiwu Technology’s shares, although there is no assurance that the post-split share price will reflect the reverse split ratio. This development comes as the company faces a delisting notice from Nasdaq due to its share price remaining below $1.00 for 30 consecutive business days. To regain compliance, Meiwu Technology must elevate its share price to at least $1.00 for 10 consecutive business days before August 26, 2025. The company may consider an additional reverse stock split as part of its efforts to meet Nasdaq’s listing requirements. Meiwu Technology has not provided further details on its plans to address the compliance issue. These recent developments are part of the company’s strategic transition to the skincare industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.